Skip to search formSkip to main contentSkip to account menu
Epidemiology of anxiety disorders in the 21st century
TLDR
There is no evidence that the prevalence rates of anxiety disorders have changed in the past years, but in cross-cultural comparisons, prevalence rates are highly variable and heterogeneity is due to differences in methodology than to cultural influences.
View on Taylor & Francis
Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale
  • B. Bandelow
  • Psychology, Medicine
    International clinical psychopharmacology
  • 1 June 1995
TLDR
The new Panic and Agoraphobia Scale (P&A) was developed to assess the degree of severity of these disorders after a diagnosis has been made according to the criteria of the DSM-III-R/IV or the ICD-10.
View on Wolters Kluwer
Efficacy of treatments for anxiety disorders: a meta-analysis
TLDR
In direct comparisons with control groups, all investigated drugs, except for citalopram, opipramol and moclobemide, were significantly more effective than placebo; this finding cannot be explained by heterogeneity, publication bias or allegiance effects.
View on Wolters Kluwer
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for…
This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and…
View on SAGE
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
TLDR
Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.
View on Taylor & Francis
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls
View on Elsevier
Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care
TLDR
A combination of medication and cognitive behavior/exposure therapy was shown to be a clinically desired treatment strategy and may improve treatment of anxiety disorders, OCD, and PTSD in primary care.
View on Taylor & Francis
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.
TLDR
It is suggested that regular aerobic exercise alone, in comparison with placebo, is associated with significant clinical improvement in patients suffering from panic disorder, but that it is less effective than treatment with clomipramine.
View on PubMed
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
TLDR
These British Association for Psychopharmacology guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.
View on SAGE
Assessing the efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems
TLDR
In this paper, commonly used anxiety scales are discussed with regard to their relevance in the assessment of PDA and it is shown that the five subscores of the scale contribute independently and almost equally to the prediction of Pda severity.
View on Wolters Kluwer
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License